Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
Keywords:
Soft tissue sarcomas, STS, dissemination, staging, treatmentAbstract
Soft tissue sarcomas (STS) are rare tumors, approximately 1% of all malignant tumors worldwide, and are responsible for 2% of cancer mortality. The survival of a patient with sarcoma depends on several factors: tumor size, location, histology, mitotic rate and superficial or deep location. The STS can be classified into two different stages: those that are localized and those that disseminated to distance, defining different forms of treatment and intervention. The treatment requires the intervention of a multidisciplinary team with trained professionals in specialized centers. Current treatment options include surgery, radiotherapy and chemotherapy, according to the grade, stage of disease and the presence or absence of metastasis.
Downloads
References
Baratti D, Pennacchioli E, Casali PG, et al. Ephithelioid sarcoma: prognostic factores and survival in a series of patients treated at a single institution. Ann Surg Oncol 2007; 14:3542-51.
Borden EC, Amato DA, Rosenbaum C, et al. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcoma. J Clin Oncol 1987; 5: 840-50.
Brunicardi FC, et al., editors. Schwartz’s Principles of Surgery, 9th edition. New York: McGraw-Hill; 2010.
Buesa JM, Fra J, Antón A., et al. Activity of doxorubicin after high-dose ifosfamide in adult patients with advanced soft tissue sarcomas: A Study of the Spanish Group for Research on Sarcomas (GEIS). Ann Oncol 1998; 9:783-85.
Quintero C. Trabectedina en el tratamiento de sarcomas de partes blandas. Sociedad Española de Oncología Médica, vol. 3, núm. 8, junio 2008, Separata n.º 2.
Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701-11.
Clinical Practice Guidelines in Oncology, Soft Tissue Sarcoma V1.2011
em http://www2.mdanderson.org/depts/Oncolog/articles/11/6-jun/6-11-compass.html.
ESMO clinical recommendations for diagnosis, treatment and followup. Ann Oncol. 2007; 18 (2): ii74- ii76).
Global Initiative, acesso em Janeiro 2014: http://sarcomahelp.org/index.html?tpm=1_2.
García Del Muro X, Martín J, Maurel J, Cubedo R, Bagué S, de Álava E, Pousa AL, Narváez JA, Ortiz E, Pomés J, Poveda A, Romasanta LP, Tendero O, Viñals JM; Grupo Español de Investigación en Sarcomas (GEIS). [Soft tissue sarcomas: clinical practice guidelines] Med Clin (Barc). 2011 Apr 9;136(9):408.e1-8. doi: 10.1016/j.medcli.2011.02.004. Epub 2011 Mar 15. Spanish.
Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, Vilain MO, Mandard AM, Le Doussal V, Leroux A, Jacquemier J, Duplay H, Sastre-Garau X, Costa J. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997 Jan;15(1):350-62.
Lawrence W Jr, Donegan WL, Nachimuth N, et al: Adult soft tissue sarcomas: A Pattern of Care. Survey of the American College of Surgeons. Ann. Surg 1987; 205:349-59.
Le Cesne A. 13 years of trabectedin, 5 years of Yondelis®: what have we learnt? Expert Rev. Anticancer Ther. 2013; 13 (Suppl: 1):11-9.
Poveda A, Querejeta A y Buesa JM. Sarcomas de partes blandas. In Oncología Médica, vol .2, pp. 1041-60. Editorial Nova Sidonia, Madrid, 1999.
Poveda A, Lopez-Pousa A, Martín J, et al. Liposomal Doxorubicin (Caelyx®) in advanced soft tissue sarcoma patients: A phase II study of the Spanish Group for Research on Sarcomas. Proceed ASCO, 1999; 18: 553.
Rosenthal DS. Changing Trends. CA Cancer J Clin 1998; 98:3-4
Sarcomas. In Cancer: Principles and Practice of Oncology: De Vita VT, Hellman S and Rosenberg SA (edts). 5.ª ed. Lippincott-Raven Publishers, Philadelphia; 1997.
Sarcomas. In Cancer Medicine: Holland JF, Bast RC, Morton DL, Frei III E, Kufe DW, Weichselbaum RR (edts). 4.ª ed. Lea & Felbiger, Baltimore 1997.
Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figures 2014. Em: Cancer.Net, visita em Janeiro 2014 - http://www.cancer.net/cancer-types/sarcoma/statistics
Páginas Web especializadas em epidemiologia dos STS: www.iarc.fr | www-dep.iarc.fr | www-dep.iarc.fr/nordcan/English/frame.asp
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 M. Jorge Freitas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
